Skip to content
PubMed This is a summary of 14 peer-reviewed journal articles Updated
Pediatrics

What Is the Interferon Signature Test for AGS?

At a Glance

The interferon signature test is a specialized blood test that measures immune system overdrive in children with Aicardi-Goutières syndrome (AGS). Doctors use it to help diagnose the condition, track underlying inflammation, and monitor how well treatments like JAK inhibitors are working.

The interferon signature is a specialized blood test that measures whether a child’s immune system is stuck in “overdrive.” Specifically, it looks at the activity driven by a chemical messenger called Type I Interferon, which is unusually active in children with Aicardi-Goutières syndrome (AGS) [1][2]. Doctors use this test initially to help diagnose the condition, and later to periodically monitor how well treatments are working to calm the immune system [3].

What Does the Test Actually Measure?

In a healthy body, interferon acts as an alarm system to fight off viral infections. In AGS, genetic differences cause the body to trigger this alarm constantly, even when no virus is present, creating chronic inflammation [4].

The blood test doesn’t just measure the interferon itself. Instead, it measures interferon-stimulated genes (ISGs)—the specific genes in the body’s cells that are “turned on” by this false alarm [5][1]. When a large number of these genes are highly active, the test result shows an elevated “interferon signature.”

Why is it Used for Diagnosis?

Because AGS is classified as an “interferonopathy”—a disease caused by too much interferon—finding an elevated signature is a powerful clue that helps doctors confirm an AGS diagnosis [6]. It is especially helpful in making a diagnosis when a child’s genetic testing results are uncertain [7]. The signature can sometimes even be detected in the newborn period, before major clinical symptoms appear [8].

However, a normal or negative test does not completely rule out AGS. Children with certain specific genetic mutations, such as the RNASEH2B mutation, are more likely to have a lower or negative interferon signature compared to those with other AGS genes [9][8].

What to Expect: Logistics and Lab Results

Because the interferon signature test is highly specialized, it usually cannot be processed by a local pediatrician’s standard lab. The blood sample typically needs to be sent to a specific research or reference laboratory [5]. As a result, it can take several weeks to get the results back. The test typically does not require fasting.

When reviewing the results on a lab portal, you won’t see a single “interferon level.” Instead, you will see a composite “score” calculated from the activity of multiple ISGs. Every specialty lab has its own scale for what constitutes a “normal” versus “elevated” score, so your doctor will compare your child’s score against that specific lab’s baseline [3].

Crucially, because the test measures immune response, an ordinary viral infection (like a common cold) at the time of the blood draw can temporarily spike the score. Always tell your doctor if your child was sick when the blood was drawn, as this provides important context for interpreting the results.

Why Does My Child Need the Test Repeatedly?

Once a child is diagnosed with AGS, doctors will order the interferon signature test periodically for two main reasons:

  • Monitoring Medication Effectiveness: If your child is prescribed a JAK inhibitor (such as baricitinib), this medication works specifically by blocking the harmful interferon alarm signals [10][11]. Doctors use the interferon signature test to verify that the medication is doing its job. A dropping interferon score is one sign that the drug is helping to calm the immune overdrive, though your doctor will also look closely at clinical improvements [12][13]. It can take weeks or months of consistent medication use to see significant changes in the score.
  • Tracking Overall Disease Activity: The signature serves as a biomarker to help doctors see how active the underlying inflammation is over time [3].

While the test is excellent for measuring internal inflammation, it does have limitations. Research shows that a child’s interferon score does not always perfectly match their clinical symptoms or predict their future neurological development [14][5]. Therefore, doctors will always look at the test results alongside your child’s physical health, developmental progress, and symptom history.

Common questions in this guide

What does the interferon signature test actually measure?
It measures the activity of interferon-stimulated genes (ISGs) in the blood. This shows whether your child's immune system is constantly triggered by excessive Type I Interferon, causing chronic inflammation.
Can a normal interferon test rule out Aicardi-Goutières syndrome?
No, a normal or negative test does not completely rule out AGS. Children with specific genetic variations, such as the RNASEH2B mutation, may naturally have a lower or normal interferon signature despite having the condition.
Should my child take the interferon test if they have a cold?
You should always inform your doctor if your child is sick when the blood is drawn. Because the test measures immune response, an ordinary viral infection like a cold can temporarily spike the interferon score.
How long does it take to get interferon signature test results?
It typically takes several weeks to get the results back. The blood sample cannot be processed at a standard pediatric clinic and must be sent to a highly specialized research or reference laboratory.
Why do doctors need to repeat the interferon signature test?
Doctors repeat the test periodically to monitor overall disease activity and check if treatments like JAK inhibitors are working. A decreasing score indicates that the medication is successfully blocking the harmful immune signals.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.What was my child's baseline interferon score before starting treatment, and what is the most recent score?
  2. 2.What is the specific reference range for the specialty lab running our test, and what score is considered normal?
  3. 3.Based on my child's specific genetic mutation, should we expect their interferon signature to be highly elevated or closer to normal?
  4. 4.How often will we need to repeat the blood draw to monitor disease activity, and where will the sample be sent?
  5. 5.If my child has a cold or common virus around the time of their scheduled blood draw, should we reschedule the test?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (14)
  1. 1

    Ribonuclease H2 mutations induce a cGAS/STING-dependent innate immune response.

    Mackenzie KJ, Carroll P, Lettice L, et al.

    The EMBO journal 2016; (35(8)):831-44 doi:10.15252/embj.201593339.

    PMID: 26903602
  2. 2

    [When to consider type I interferonopathy in adulthood?]

    David C, Frémond ML

    La Revue de medecine interne 2022; (43(6)):347-355 doi:10.1016/j.revmed.2021.11.003.

    PMID: 35177256
  3. 3

    Sine causa tetraparesis: A pilot study on its possible relationship with interferon signature analysis and Aicardi Goutières syndrome related genes analysis.

    Galli J, Gavazzi F, De Simone M, et al.

    Medicine 2018; (97(52)):e13893 doi:10.1097/MD.0000000000013893.

    PMID: 30593198
  4. 4

    Analysis of clinical characteristics of children with Aicardi-Goutieres syndrome in China.

    Wang W, Wang W, He TY, et al.

    World journal of pediatrics : WJP 2022; (18(7)):490-497 doi:10.1007/s12519-022-00545-1.

    PMID: 35551623
  5. 5

    Interferon-Stimulated Gene Expression as a Preferred Biomarker for Disease Activity in Aicardi-Goutières Syndrome.

    Wang BX, Grover SA, Kannu P, et al.

    Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research 2017; (37(4)):147-152 doi:10.1089/jir.2016.0117.

    PMID: 28387595
  6. 6

    Aicardi-Goutières syndrome: A monogenic type I interferonopathy.

    Liu A, Ying S

    Scandinavian journal of immunology 2023; (98(4)):e13314 doi:10.1111/sji.13314.

    PMID: 37515439
  7. 7

    PNPT1 mutations may cause Aicardi-Goutières-Syndrome.

    Bamborschke D, Kreutzer M, Koy A, et al.

    Brain & development 2021; (43(2)):320-324 doi:10.1016/j.braindev.2020.10.005.

    PMID: 33158637
  8. 8

    Neonatal detection of Aicardi Goutières Syndrome by increased C26:0 lysophosphatidylcholine and interferon signature on newborn screening blood spots.

    Armangue T, Orsini JJ, Takanohashi A, et al.

    Molecular genetics and metabolism 2017; (122(3)):134-139 doi:10.1016/j.ymgme.2017.07.006.

    PMID: 28739201
  9. 9

    Molecular Genetics and Interferon Signature in the Italian Aicardi Goutières Syndrome Cohort: Report of 12 New Cases and Literature Review.

    Garau J, Cavallera V, Valente M, et al.

    Journal of clinical medicine 2019; (8(5)) doi:10.3390/jcm8050750.

    PMID: 31130681
  10. 10

    Lung involvement in monogenic interferonopathies.

    Cazzato S, Omenetti A, Ravaglia C, Poletti V

    European respiratory review : an official journal of the European Respiratory Society 2020; (29(158)) doi:10.1183/16000617.0001-2020.

    PMID: 33328278
  11. 11

    Exploring emerging JAK inhibitors in the treatment of Aicardi-Goutières syndrome.

    Politano D, Tonduti D, Battini R, et al.

    Expert opinion on emerging drugs 2024; 1-19 doi:10.1080/14728214.2024.2445508.

    PMID: 39704072
  12. 12

    "CANDLE syndrome: A closer look at a rare autoinflammatory disorder".

    Singh S, Sharma AK

    Journal of translational autoimmunity 2026; (12()):100339 doi:10.1016/j.jtauto.2025.100339.

    PMID: 41466885
  13. 13

    Baricitinib Treatment in RNU7-1-Associated Aicardi-Goutières Syndrome in a South African Child: A Case Report.

    Spracklen TF, Akhalwaya S, Ackermann S, et al.

    American journal of medical genetics. Part A 2025; (197(5)):e63978 doi:10.1002/ajmg.a.63978.

    PMID: 39748568
  14. 14

    Development of a neurologic severity scale for Aicardi Goutières Syndrome.

    Adang LA, Gavazzi F, Jawad AF, et al.

    Molecular genetics and metabolism 2020; (130(2)):153-160 doi:10.1016/j.ymgme.2020.03.008.

    PMID: 32279991

This page provides information about the interferon signature test for educational purposes only. Always consult your pediatric neurologist or immunologist for specific medical advice and laboratory test interpretation.

Get notified when new evidence is published on Aicardi-Goutières syndrome.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.